Related Experiment Video
Updated: May 2, 2026
Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids
Published on: August 2, 2024
Determination of Cell Death Induced by Lovastatin on Human Colon Cell Line HT29 Using the Comet Assay
Marzieh Jafari1, Mohsen Rezaei1, Heibatullah Kalantari1
1Department of Pharmacology and Toxicology, School of Pharmacy, Ahvaz Jundishpur University of Medical Sciences, Ahvaz, IR Iran.
Background:
Apoptosis or programmed cell death is an essential process for elimination of damaged cells. Also, induction of apoptosis is fundamental for treating cancer. Screening for agents that induce apoptosis in tumor cells help in the development of novel agents for cancer treatment. Numerous studies suggest that the exposure of tumor cells to statins can lead to cell death via two separate processes: apoptosis or necrosis. Severe fragmentation of DNA during apoptosis can be readily measured by the neutral comet assay. Migration of DNA fragments of apoptotic cells by the electrical field can produce comet-like images.
Objectives:
The aim of this study was to determine the type of cell death induced by lovastatin on human colon tumor cells by using the neutral comet assay and to evaluate the utility of this method for detection of apoptosis.
Materials And Methods:
HT29 cells were grown in DMEM medium then exposed to different concentrations of lovastatin, and DNA fragmentation associated with apoptosis was detected by the neutral comet assay method.
Results:
Lovastatin induced an apoptotic response in the HT29 cell line and produced a comet pattern similar to the positive control.
Conclusions:
This study showed that lovastatin can induce apoptosis in the HT29 cell line and confirmed the utility of comet assay for detection of apoptosis.
Insights
Lovastatin induces apoptosis in human colon tumor cells. The neutral comet assay effectively detects this programmed cell death, confirming its utility for cancer research.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Apoptosis, or programmed cell death, is crucial for removing damaged cells and a key target in cancer treatment.
- Statins have been shown to induce cell death, including apoptosis and necrosis, in tumor cells.
- DNA fragmentation during apoptosis can be quantified using the neutral comet assay, which visualizes fragmented DNA as comet-like images.
Purpose of the Study:
- To investigate the specific type of cell death induced by lovastatin in human colon tumor cells.
- To assess the effectiveness of the neutral comet assay in detecting apoptosis induced by lovastatin.
Main Methods:
- Human colon tumor cells (HT29) were cultured in DMEM.
- Cells were treated with varying concentrations of lovastatin.
- DNA fragmentation indicative of apoptosis was analyzed using the neutral comet assay.
Main Results:
- Lovastatin treatment resulted in an apoptotic response in the HT29 cell line.
- The observed DNA fragmentation pattern in lovastatin-treated cells resembled that of the positive control.
Conclusions:
- Lovastatin effectively induces apoptosis in the HT29 human colon tumor cell line.
- The neutral comet assay is a reliable method for detecting apoptosis in this context.
